argenx SE
ARGX
$615.46
-$4.51-0.73%
Weiss Ratings | ARGX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Very Weak | |||
Risk Index | Weak | |||
Risk Grade | D | |||
Reward Grade | E | |||
Rating Factors | ARGX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | -- | |||
Growth Index | Good | |||
Efficiency Index | Very Weak | |||
Solvency Index | Excellent | |||
Total Return Index | Good | |||
Volatility Index | Fair | |||
Beta / Standard Deviation | ARGX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 0.29 | |||
Price History | ARGX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | 6.04% | |||
30-Day Total Return | -8.38% | |||
60-Day Total Return | -1.69% | |||
90-Day Total Return | 4.50% | |||
Year to Date Total Return | -0.76% | |||
1-Year Total Return | 72.42% | |||
2-Year Total Return | 68.63% | |||
3-Year Total Return | 106.18% | |||
5-Year Total Return | 417.89% | |||
52-Week High % Change | -8.59% | |||
52-Week Low % Change | 77.21% | |||
Price | ARGX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $678.21 | |||
52-Week Low Price | $349.86 | |||
52-Week Low Price (Date) | Mar 20, 2024 | |||
52-Week High Price (Date) | Jan 14, 2025 | |||
Valuation | ARGX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 37.49B | |||
Enterprise Value | 33.96B | |||
Price/Earnings (TTM) | -- | |||
Earnings Per Share (TTM) | -2.48 | |||
Earnings Per Share Growth | -65.41% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 32.11 | |||
Price/Book (Q) | 8.70 | |||
Enterprise Value/Revenue (TTM) | 27.23 | |||
Price | $615.46 | |||
Enterprise Value/EBITDA (TTM) | -165.54 | |||
Enterprise Value/EBIT | -130.32 | |||
Market Cap Category | Large Cap | |||
Dividends and Shares | ARGX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 64.59M | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | ARGX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 31 10 703 8441 | |||
Address | -- | |||
Website | www.argenx.com | |||
Country | Netherlands | |||
Year Founded | 2008 | |||
Profitability | ARGX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | -- | |||
Profit Margin | -- | |||
Management Effectiveness | ARGX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | -- | |||
Return on Equity | -- | |||
Income Statement | ARGX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | -- | |||
Total Revenue (TTM) | -- | |||
Revenue Per Share | $19.31 | |||
Gross Profit (TTM) | -- | |||
EBITDA (TTM) | -- | |||
EBIT (TTM) | -- | |||
Net Income (TTM) | -- | |||
Net Income Avl. to Common (TTM) | -- | |||
Total Revenue Growth (Q YOY) | 74.15% | |||
Earnings Growth (Q YOY) | 130.80% | |||
EPS Diluted (TTM) | -- | |||
EPS Diluted Growth (Q YOY) | 126.49% | |||
Balance Sheet | ARGX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 3.10B | |||
Cash Per Share (Q) | $48.03 | |||
Total Current Assets (Q) | 4.26B | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 4.26B | |||
Current Ratio (Q) | 8.534 | |||
Book Value Per Share (Q) | $71.28 | |||
Total Assets (Q) | 4.80B | |||
Total Current Liabilities (Q) | 499.63M | |||
Total Debt (Q) | 33.96M | |||
Total Liabilities (Q) | 534.31M | |||
Total Common Equity (Q) | 4.26B | |||
Cash Flow | ARGX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -- | |||
Cash from Financing (TTM) | -- | |||
Net Change in Cash (TTM) | -- | |||
Levered Free Cash Flow (TTM) | -- | |||
Cash from Operations (TTM) | -- | |||